South & Central America Anatomic Pathology Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The anatomic pathology market size is expected to reach US$ 1,661.29 million by 2031 from US$ 1,072.82 million in 2023. The market is estimated to record a CAGR of 5.6% from 2023 to 2031.

Executive Summary and South & Central America Anatomic Pathology Market Analysis:

The anatomic pathology market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The presence of well-developed and established healthcare sectors, increasing support from governments, and rising research and developments are creating favorable conditions for the growth of the market in this region. Further, the growing prevalence of strokes, neurological disorders, and cancer; a rise in the geriatric population; and the adoption of unhealthy lifestyles are the prevailing challenges in this market, bolstering the demand for anatomic pathology devices and services.

South & Central America Anatomic Pathology Market Strategic Insights

Get more information on this report Request Free Sample PDF

South & Central America Anatomic Pathology Market Segmentation Analysis

Key segments that contributed to the derivation of the anatomic pathology market analysis are product and services, application, and end user.

• Based on product and services, the South & Central America anatomic pathology market is segmented into services, instruments, and consumables. The instruments held the largest share of the market in 2023. The services segment is further sub segmented into histopathology and cytopathology. The instruments segment is further sub segmented into microtomes and cryostat, automatic stainer's, tissue processors, and others.
• By application, the South & Central America anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest share of the market in 2023.
• By end user, the South & Central America anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2023.

South & Central America Anatomic Pathology Market Outlook

Small and big companies operating in the anatomic pathology market are increasingly adopting various strategies such as geographic expansion, new product launches, and technological advancements to boost their revenues. A few recent developments in the anatomic pathology market are mentioned below:

• In May 2024, Quest Diagnostic and PathAI entered a multifaceted collaboration to accelerate the adoption of digital and AI pathology innovations to improve quality, speed, and efficiency in diagnosing cancer and other diseases. Under the terms of this definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides digital and anatomic pathology laboratory services.
• In April 2024, Medline became the distributor of products of Epredia, a member of PHC Group. Epredia provides solutions for precision cancer diagnostics and tissue diagnostics in the anatomical pathology field. Through this agreement, Medline offers anatomical pathology products from Epredia to laboratories and customers, thus expanding Medline's extensive portfolio of lab products, devices, and equipment.

Therefore, the rise in strategic initiatives by market players boosts the growth of the anatomic pathology market.

South & Central America Anatomic Pathology Market Country Insights

Based on country, the South & Central America anatomic pathology market comprises Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2023.

Brazil is the fifth largest country in the world both by area and by population and is experiencing the fastest demographic aging worldwide. The population in the country is aging at a rapid pace. Moreover, regional and historical socioeconomic inequalities hamper the overall growth of Brazil. The growing aging population leads to several chronic conditions, such as cancer, orthopedic conditions, neurovascular disorders, and diabetes, propelling the adoption of medical devices and diagnostic tests. Additionally, the increasing prevalence of cancer is projected to drive the growth of the anatomic pathology market in the country. According to an article published in Cancer Research Prevention in October 2021, cervical cancer incidence is growing, with an estimated 16,710 new cases in 2020; moreover, ~15.38 per 100,000 women are at risk of developing this condition. Brazilian guidelines recommend cytology tests every 3 years for women aged 25–64, with two consecutive negative annual results. The Unified Health System (SUS) in Brazil is one of the world's largest public health systems. It has a unique responsibility to provide services across the country, encompassing significantly different populations and healthcare settings. Such a lucrative environment in the country is attracting a number of prime players to take strategic measures to fulfill their geographic expansion goals. In September 2021, the Digital Pathology Open Environment was launched by Roche to encourage collaboration among software developers to enhance patient outcomes and increase personalized healthcare through novel image analysis technologies. Furthermore, new product launches and approvals by them are estimated to drive the growth of the anatomic pathology market in Brazil during the forecast period.

South & Central America Anatomic Pathology Market Report Highlights

South & Central America Anatomic Pathology Market Company Profiles

Some of the key players operating in the market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Anatomic Pathology Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

South & Central America Anatomic Pathology Market Country and Regional Insights